hERG Potassium Channel Blockade by the HCN Channel Inhibitor Bradycardic Agent Ivabradine

BACKGROUND: Ivabradine is a specific bradycardic agent used in coronary artery disease and heart failure, lowering heart rate through inhibition of sinoatrial nodal HCN‐channels. This study investigated the propensity of ivabradine to interact with KCNH2‐encoded human Ether‐à‐go‐go–Related Gene (hER...

Descripción completa

Detalles Bibliográficos
Autores principales: Melgari, Dario, Brack, Kieran E., Zhang, Chuan, Zhang, Yihong, El Harchi, Aziza, Mitcheson, John S., Dempsey, Christopher E., Ng, G. André, Hancox, Jules C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579960/
https://www.ncbi.nlm.nih.gov/pubmed/25911606
http://dx.doi.org/10.1161/JAHA.115.001813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579960/
https://www.ncbi.nlm.nih.gov/pubmed/25911606
http://dx.doi.org/10.1161/JAHA.115.001813

Ejemplares similares